| Variation of COMT Val158Met Polymorphism Between COM-ON Patients and METHADOSE Patients (NCT01570699) | Assistance Publique - Hôpitaux de Paris | 2012-12-01 |
| Comparative Evaluation of PUSPENs and C&Cs (NCT02698098) | University of Malaya | 2012-08-01 |
| Pioglitazone to Treat Opioid Withdrawal Symptoms (NCT01517165) | National Institute on Drug Abuse (NIDA) | 2012-01-04 |
| Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects (NCT01536925) | Wayne State University | 2011-12-01 |
| A Comparison of PR Oxycodone/Naloxone and PR Oxycodone After Cardiac Surgery (NCT01374763) | Kati Järvelä | 2011-07-01 |
| Drug-Drug Interaction Study Between Telaprevir and Buprenorphine (NCT01275599) | Vertex Pharmaceuticals Incorporated | 2011-01-01 |
| Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE) (NCT01344122) | Rhode Island Hospital | 2010-10-01 |
| Medications Development for Drug Abuse Disorders (NCT01188421) | Johns Hopkins University | 2010-10-01 |
| Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo (NCT01595867) | Pfizer | 2010-08-01 |
| Study of Computer-Based Treatment for Drug Dependence (NCT01315184) | Yale University | 2010-07-01 |
| Trial of Methadone Maintenance Versus Methadone Detox in Jail (NCT01874964) | The Miriam Hospital | 2010-06-01 |
| Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users (NCT01108679) | Albert Einstein College of Medicine | 2009-12-01 |
| Methylnaltrexone for Opioid-induced Constipation in Cancer Patients (NCT01004393) | University of Vermont | 2009-10-01 |
| Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2 (NCT00000299) | University of California, Los Angeles | 2008-10-01 |
| Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal (NCT00723177) | New York State Psychiatric Institute | 2008-10-01 |
| Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients (NCT00780702) | National Institute on Drug Abuse (NIDA) | 2008-05-08 |
| Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users (NCT00270257) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-05-01 |
| Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444) (NCT00725608) | Indivior Inc. | 2008-05-01 |
| Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC) (NCT00698737) | Wayne State University | 2008-04-01 |
| Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603) (NCT00723749) | Indivior Inc. | 2008-03-01 |
| Effects of Stress and Other Factors on Opiate Drug Choice. (NCT00684840) | Wayne State University | 2008-03-01 |
| Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone (NCT00637000) | Indivior Inc. | 2008-03-01 |
| Safety and Tolerability of Buprenorphine/Naloxone Film Strips (NCT00640835) | Indivior Inc. | 2008-02-01 |
| Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate Abusers (NCT00726960) | Karolinska University Hospital | 2008-01-01 |
| Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial (NCT00684554) | New York State Psychiatric Institute | 2007-12-01 |
| Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse (NCT00734461) | Pain Therapeutics | 2007-08-01 |
| Effects of Environmental Factors on Opiate Drug Choice in Opioid Dependent Individuals. (NCT00608504) | Wayne State University | 2007-07-01 |
| Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, Switzerland (NCT00473993) | Seidenberg, Arztpraxis A., M.D. | 2007-07-01 |
| The Effects of Pharmacotherapy on Brain Mechanisms Underlying Cocaine Dependence. (NCT00396734) | Hadassah Medical Organization | 2007-04-01 |
| Sustained Release d-Amphetamine & Buprenorphine on Drug Seeking Behavior in Opioid & Cocaine Dependent Individuals (NCT00429767) | Wayne State University | 2007-01-01 |
| Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia (NCT00218374) | National Institute on Drug Abuse (NIDA) | 2006-10-01 |
| Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1 (NCT00142935) | The Miriam Hospital | 2006-09-01 |
| Addiction Treatment in Russia: Oral vs. Naltrexone Implant (NCT00218426) | University of Pennsylvania | 2006-07-01 |
| Buprenorphine HIV Care Integration Project (NCT00348868) | University of Miami | 2006-07-01 |
| Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care (NCT00471042) | New York State Psychiatric Institute | 2006-06-01 |
| Prescription Opioid Addiction Treatment Study (POATS) (NCT00316277) | Mclean Hospital | 2006-05-01 |
| Interactive Voice Response (IVR) for Methadone Patients (NCT00237406) | Butler Hospital | 2006-01-01 |
| Assessment of Tramadol as a Treatment for Opioid Addiction (NCT00301210) | Johns Hopkins University | 2006-01-01 |
| Employment-based Reinforcement of Naltrexone Ingestion and Abstinence (NCT00149669) | Johns Hopkins University | 2005-12-01 |
| Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients (NCT00295308) | National Institute on Drug Abuse (NIDA) | 2005-11-08 |
| Effects of Post-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals (NCT00218361) | Wayne State University | 2005-08-01 |
| Buprenorphine and Integrated HIV Care Evaluation (NCT00124358) | The New York Academy of Medicine | 2005-08-01 |
| RCT Comparing Methadone and Buprenorphine in Pregnant Women (NCT00271219) | Johns Hopkins University | 2005-07-01 |
| Project BEST: Buprenorphine Entry Into Substance Abuse Treatment (NCT02583243) | Yale University | 2005-05-01 |
| Addition of Naltrexone to Methadone Taper (NCT00135759) | National Institute on Drug Abuse (NIDA) | 2005-04-01 |
| Tramadol to Reduce Opioid Withdrawal Symptoms (NCT00142896) | National Institute on Drug Abuse (NIDA) | 2005-02-01 |
| Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1 (NCT00142909) | Yale University | 2005-02-01 |
| Prescription Opioid Effects in Abusers Versus Non-Abusers (NCT00158184) | New York State Psychiatric Institute | 2004-06-01 |
| Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids (NCT00218101) | National Institute on Drug Abuse (NIDA) | 2004-05-01 |
| Opioid Agonist and Antagonist Effects on Opioid Dependence (NCT00142727) | National Institute on Drug Abuse (NIDA) | 2004-01-01 |
| Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals (NCT00218309) | National Institute on Drug Abuse (NIDA) | 2003-09-01 |
| Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1 (NCT00078130) | University of Pennsylvania | 2003-07-01 |
| Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1 (NCT00078117) | University of California, Los Angeles | 2003-06-01 |
| The Therapeutic Workplace Initiation Study (NCT00249470) | Johns Hopkins University | 2003-04-01 |
| Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone (NCT00000243) | National Institute on Drug Abuse (NIDA) | 2002-09-01 |
| Fetal Neurobehavioral Development in Methadone Maintained Pregnancies (NCT00067184) | Johns Hopkins University | 2002-09-01 |
| Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens (NCT00218127) | National Institute on Drug Abuse (NIDA) | 2001-11-01 |
| Lofexidine for Opiate Withdrawal - 1 (NCT00032942) | National Institute on Drug Abuse (NIDA) | 2001-04-01 |
| Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts (NCT00142779) | National Institute on Drug Abuse (NIDA) | 2001-04-01 |
| Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence (NCT00134888) | National Institute on Drug Abuse (NIDA) | 2000-12-01 |
| Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers (NCT00134875) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-12-01 |
| Methadone Levels in Breast Milk of Women Taking Methadone for Opiate Addiction - 2 (NCT00218010) | National Institute on Drug Abuse (NIDA) | 2000-11-01 |
| Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1 (NCT00023283) | Yale University | 2000-08-01 |
| Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5 (NCT00000330) | University of Colorado, Denver | 1999-10-01 |
| HIV Counseling Intervention for Methadone-Maintained Patients - 2 (NCT00061100) | New York State Psychiatric Institute | 1999-10-01 |
| Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22 (NCT00000240) | University of Vermont | 1999-04-01 |
| Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4 (NCT00000329) | University of Colorado, Denver | 1999-04-01 |
| Effect Of Case Management Following Discharge From Methadone Treatment (NCT00018226) | US Department of Veterans Affairs | 1998-04-01 |
| Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13 (NCT00000261) | University of Chicago | 1997-11-01 |
| Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 (NCT00000320) | National Institute on Drug Abuse (NIDA) | 1997-10-01 |
| Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16 (NCT00000264) | University of Chicago | 1997-09-01 |
| Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20 (NCT00000238) | National Institute on Drug Abuse (NIDA) | 1997-08-01 |
| Subjective Effects of Nitrous Oxide in Dental Patients - 17 (NCT00000265) | University of Chicago | 1997-07-01 |
| Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3 (NCT00000328) | University of Colorado, Denver | 1997-07-01 |
| Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12 (NCT00000260) | University of Chicago | 1997-06-01 |
| Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2 (NCT00000327) | University of Colorado, Denver | 1997-06-01 |
| Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1 (NCT00000326) | University of Colorado, Denver | 1997-04-01 |
| Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users (NCT00158236) | National Institute on Drug Abuse (NIDA) | 1997-01-01 |
| Effects of Combined Alcohol and Nitrous Oxide Intake - 15 (NCT00000263) | University of Chicago | 1997-01-01 |
| Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1 (NCT00000352) | National Institute on Drug Abuse (NIDA) | 1996-12-01 |
| Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14 (NCT00000262) | University of Chicago | 1996-11-01 |
| Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1 (NCT00015028) | National Institute on Drug Abuse (NIDA) | 1996-11-01 |
| Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2 (NCT00015041) | National Institute on Drug Abuse (NIDA) | 1996-11-01 |
| Buprenorphine and Naloxone Combination Study - 10 (NCT00015288) | National Institute on Drug Abuse (NIDA) | 1996-11-01 |
| Trial of Buprenorphine/Naloxone for Opiate Dependence - 2 (NCT00000353) | National Institute on Drug Abuse (NIDA) | 1996-10-01 |
| Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence (NCT00134914) | National Institute on Drug Abuse (NIDA) | 1996-08-01 |
| Evaluation of Liquid vs. Tablet Buprenorphine - 6 (NCT00000341) | National Institute on Drug Abuse (NIDA) | 1996-08-01 |
| Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11 (NCT00000259) | University of Chicago | 1996-08-01 |
| Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3 (NCT00000354) | National Institute on Drug Abuse (NIDA) | 1996-07-01 |
| Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2 (NCT00000319) | Yale University | 1996-06-01 |
| Role of Instructions in Nitrous Oxide Effects and Choice - 10 (NCT00000258) | University of Chicago | 1996-04-01 |
| Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10 (NCT00000345) | National Institute on Drug Abuse (NIDA) | 1996-04-01 |
| Buprenorphine Detox With Two Types of Treatment. BBD II - 11 (NCT00000229) | University of Vermont | 1995-10-01 |
| Activity Monitoring Assessment of Opiate Withdrawal - 4 (NCT00000335) | National Institute on Drug Abuse (NIDA) | 1995-09-30 |
| Effects of Alcohol History on Effects of Nitrous Oxide - 9 (NCT00000257) | University of Chicago | 1995-09-01 |
| Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8 (NCT00000256) | University of Chicago | 1995-08-01 |
| Buprenorphine Combination Tablet Feasibility - 1 (NCT00000298) | National Institute on Drug Abuse (NIDA) | 1995-08-01 |
| A Laboratory Model for Heroin Abuse Medications - 8 (NCT00000273) | New York State Psychiatric Institute | 1995-08-01 |
| Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7 (NCT00000255) | University of Chicago | 1995-04-01 |
| Feasibility Study of Take-Home LAAM Medication - 3 (NCT00000300) | University of California, Los Angeles | 1995-03-01 |